How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

HHS Cancels Moderna’s Award for Developing Avian Influenza Vaccine

Management of Refractory Mpox in Patients Living with HIV

35% of Evaluated Patients De-Labeled in Penicillin Allergy Study

Oral Cephalosporins Safe, Effective For Step-Down Therapy For Gram-negative Bloodstream Infections

The Changing Landscape of Antimicrobial Resistance Reporting

Antibiotic Practices For Sinusitis in Outpatient Settings Suggest Overprescribing

Integrating AI into Pharmacy Education and Stewardship

Investigational cUTI Antibiotic Meets Endpoint, Phase 3 Study Stopped Early

Some Regions of World Seeing Large Increases of COVID-19 Incidence Rates

Bridging Psychiatry and Infectious Disease

Schedule an Appointment

Quick Links

Patient Forms

Contact Us